Orange (NYSE:ORAN) stock fell 0.17% (As on October 5, 11:44:23 AM UTC-4, Source: Google Finance) after the company shares were double-upgraded to Buy from Underperform at BofA Securities analyst Titus Krahn, with analysts lifting the price target to $13 from $8.80 per share. They told investors that the French telecommunications company is “ticking all boxes,” and they see a potential 25% upside in the stock. Analysts explained that across the European telecom sector, there are several thematic drivers and financial profiles investors favor, such as improving competitive trends, a path to lower investment needs, in-market consolidation opportunities, infra ownership, and a route to growing dividend returns. Krahn is optimistic about Orange SA’s potential for growth, citing a stabilizing domestic market and a head-start in the deployment of fiber optics.
Orange’s investment case stands out, in the analysts’ view, as one of the few in the sector that captures all these elements while still at an attractive valuation.
The analysts see Orange as uniquely positioned to combine the positive thematic drivers for EU telecoms. The analysts pointed to a stabilising domestic market with improved competition, a head start in the fibre roll-out, direct involvement in Spanish consolidation, and one of the last 100%-owned tower assets with “Totem” as factors they see driving the stock and company’s performance.
Furthermore, investors are advised to closely monitor a pending deal between Orange SA and private equity-backed Masmovil Ibercom SA. This deal has generated significant anticipation within the industry, with a decision expected to be reached by the end of the year.
Meanwhile, Enovacom, the French leader for healthcare data interoperability and subsidiary of Orange Business since 2018, announces the acquisition of NEHS Digital and Xperis, both subsidiaries of the MNH group. With the integration of NEHS Digital and Xperis, Enovacom’s team will benefit from the expertise of more than 600 e-health professionals. Already recognized for its expertise in the healthcare data interoperability sector, the acquisition of Xperis completes Enovacom’s range of solutions. And by integrating NEHS Digital’s offers, Enovacom re-affirms its strong positioning in the telemedicine space and will complement its existing solutions, such as Enovacom Nomadeec. As a result of these acquisitions, Enovacom is now set to become a leading player in digital medical imagery, both as an integrator and a service provider. This is Enovacom’s second acquisition in two years, re-affirming the company’s position as one of France’s leading e-health companies.